Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    B-type natriuretic peptide is effective therapy before care.

    Witteles R, Matsuda K, Fowler MB.

    Ann Intern Med. 2004 Dec 7;141(11):895. No abstract available. PMID: 15583244 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.

    Mehra MR, McCluskey T, Barr M, Bourge RC, Jessup ML, Mancini D, Radovancevic B, Rayburn B, Taylor DO, Lilly-Hersley J, Linde P.

    Am Heart J. 2007 Jun;153(6):932-40.PMID: 17540193 [PubMed - indexed for MEDLINE]Related articles

    3.

    Brain natriuretic peptide: a diagnostic and treatment hormone for perioperative congestive heart failure.

    Skidmore KL, Russell IA.

    J Cardiothorac Vasc Anesth. 2004 Dec;18(6):780-7. Review. No abstract available. PMID: 15650995 [PubMed - indexed for MEDLINE]Related articles

    4.

    B-type natriuretic peptides in management of acute decompensated heart failure.

    Yancy CW.

    Heart Fail Clin. 2006 Jul;2(3):353-64. Review. No abstract available. PMID: 17386904 [PubMed - indexed for MEDLINE]Related articles

    5.

    Nesiritide as bridge to multi-organ transplantation: a case report.

    Cochrane AB, Fedson SE, Cronin DC 2nd.

    Transplant Proc. 2007 Jan-Feb;39(1):308-10.PMID: 17275531 [PubMed - indexed for MEDLINE]Related articles

    6.

    B-type natriuretic peptide in heart failure.

    Moe GW.

    Curr Opin Cardiol. 2006 May;21(3):208-14. Review.PMID: 16601459 [PubMed - indexed for MEDLINE]Related articles

    7.

    Brain natriuretic peptide in the contemporary management of congestive heart failure.

    Wasywich CA, Whalley GA, Doughty RN.

    Expert Rev Cardiovasc Ther. 2005 Jan;3(1):71-84. Review.PMID: 15723576 [PubMed - indexed for MEDLINE]Related articles

    8.

    The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.

    Strain WD.

    Int J Clin Pract. 2004 Nov;58(11):1081-7. Review.PMID: 15605677 [PubMed - indexed for MEDLINE]Related articles

    9.

    Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?

    Vesely DL.

    Clin Exp Pharmacol Physiol. 2006 Mar;33(3):169-76. Review.PMID: 16487258 [PubMed - indexed for MEDLINE]Related articles

    10.

    BNP-mediated vasodilatation for dialysis-dependent patient with acute heart failure syndrome in the emergency department.

    Chandra A, Otero R, Freeman D, Cairns CB.

    Ren Fail. 2008;30(1):45-50.PMID: 18197542 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.

    Fitzgerald RL, Cremo R, Gardetto N, Chiu A, Clopton P, Bhalla V, Maisel AS.

    Am Heart J. 2005 Sep;150(3):471-7.PMID: 16169326 [PubMed - indexed for MEDLINE]Related articles

    12.

    N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.

    Walsh R, Boyer C, LaCorte J, Parnell V, Sison C, Chowdhury D, Ojamaa K.

    J Thorac Cardiovasc Surg. 2008 Jan;135(1):98-105.PMID: 18179925 [PubMed - indexed for MEDLINE]Related articles

    13.

    Practical application of human B-type natriuretic peptide as a therapeutic intervention in the perioperative setting.

    Feldman DS, Sun B.

    Heart Fail Rev. 2004 Jul;9(3):203-8. Review.PMID: 15809818 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.

    Abraham WT, Cheng ML, Smoluk G; Vasodilation in the Management of Acute Congestive Heart Failure (VMAC) Study Group.

    Congest Heart Fail. 2005 Mar-Apr;11(2):59-64.PMID: 15860969 [PubMed - indexed for MEDLINE]Related articles

    15.

    Vasodilators in the management of acute heart failure.

    Elkayam U, Janmohamed M, Habib M, Hatamizadeh P.

    Crit Care Med. 2008 Jan;36(1 Suppl):S95-105. Review.PMID: 18158484 [PubMed - indexed for MEDLINE]Related articles

    16.

    Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics.

    Moffett BS, Jefferies JL, Price JF, Clunie S, Denfield S, Dreyer WJ, Towbin JA.

    Pharmacotherapy. 2006 Feb;26(2):277-80.PMID: 16466333 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.

    Miller WL, Burnett JC Jr, Hartman KA, Henle MP, Burritt MF, Jaffe AS.

    Am J Cardiol. 2005 Sep 15;96(6):837-41.PMID: 16169373 [PubMed - indexed for MEDLINE]Related articles

    18.

    B-type natriuretic peptide in the management of heart failure.

    Maurellet JD, Liu PT.

    Hong Kong Med J. 2008 Jun;14(3):216-9. Review.PMID: 18525091 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Nesiritide for acute decompensated heart failure.

    Alhosaini H.

    Am Fam Physician. 2006 Oct 15;74(8):1279; author reply 1279-80. No abstract available. PMID: 17087421 [PubMed - indexed for MEDLINE]Related articles

    20.

    Nesiritide use in pediatric patients with congestive heart failure.

    Feingold B, Law YM.

    J Heart Lung Transplant. 2004 Dec;23(12):1455-9.PMID: 15607680 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data